On November 24, 2026, Monad will unlock about 10.7 billion team tokens, representing roughly 90% of the current circulating supply of 11.83 billion MON tokens. This unlock marks the end of a one-year lock-up period and is part of a gradual release schedule over the following three years. While these tokens become available for sale, it does not guarantee they will be sold immediately or affect the price. Investors and stakers should prepare by reviewing their positions and understanding staking lock-up terms before this date. The circulating supply figures vary widely across sources, but reliable data confirms the significant size of this unlock relative to the market.
The Monad token unlock event involves releasing about 10.7 billion MON tokens. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 26, 2026 16:01 WIB: out of 50 major cryptocurrencies priced on Pluang, 35 rose and 14 fell. EOS rose 8.13% to Rp12.649 with a typical hold time of 87 days, AAVE increased 6.61% to Rp2.773.906 with 73% buy order activity, and GRT gained 6.27% to Rp503 with 97% sell order activity.
The global AI accelerator market is projected to grow from $151 billion in 2025 to $443 billion by 2030, with a compound annual growth rate of about 24%. This expansion is fueled by the rise of generative AI, large language models, and increased inve...
A growing town replaced its inefficient IT request process of spreadsheets and emails with a centralized Microsoft Power Apps hub developed by eSoftware Associates. This hub integrates project intake, risk assessment, and PMO scoring into one platfor...
No7 Software has enhanced its Anchor Loyalty & Rewards app by integrating Shopify POS, allowing merchants to run a unified loyalty program across online stores and physical shops. Customers now maintain a single points balance, tier status, and refer...
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
